Genomic Characterization of KPC-31 and OXA-181 Klebsiella pneumoniae Resistant to New Generation of β-Lactam/β-Lactamase Inhibitor Combinations

Background: Carbapenem resistant Klebsiella pneumoniae (cr-Kp) causes serious infections associated with a high mortality rate. The clinical efficacy of ceftazidime/avibactam (CZA), meropenem/vaborbactam (M/V), and imipenem/relebactam (I/R) against cr-Kp is challenged by the emergence of resistant s...

Descripción completa

Detalles Bibliográficos
Autores principales: Muresu, Narcisa, Del Rio, Arcadia, Fox, Valeria, Scutari, Rossana, Alteri, Claudia, Are, Bianca Maria, Terragni, Pierpaolo, Sechi, Illari, Sotgiu, Giovanni, Piana, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854441/
https://www.ncbi.nlm.nih.gov/pubmed/36671211
http://dx.doi.org/10.3390/antibiotics12010010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854441/
https://www.ncbi.nlm.nih.gov/pubmed/36671211
http://dx.doi.org/10.3390/antibiotics12010010

Ejemplares similares